13F filer · CIK 923093 ↗
Tudor Investment
You are looking at Q3 2016. See the latest, Q2 2026 →
Reported value
$4.27B
−9.6% on the quarter before
Positions
1,402
372 new · 555 sold out
Top 10
40.0%
of the value
Est. gain
+$81.5M
on stocks held all quarter
Est. return
+7.2%
on those stocks since Q2 2016
Positions as of Sep 30, 2016, from Tudor Investment's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 51% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2016. Striped tiles are options.
Largest buys
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrustCALL~$376.0MAdded · 6.4% → 16.1%+1,738,100 underlying
- SPDR S&P 500 ETF Trust~$81.4MNew · 0.0% → 1.9%+376,309 shares
- Ishares Msci Emerging Markets - ETF~$69.9MNew · 0.0% → 1.6%+1,867,000 shares
- Merck & Co. Incorporated~$38.0MAdded · 0.0% → 0.9%+608,900 shares
- Cst Brands Inc~$36.1MNew · 0.0% → 0.8%+750,052 shares
- Alliance Data Sys Corp~$34.3MAdded · 0.0% → 0.8%+159,660 shares
- Biogen Inc~$33.7MAdded · 0.1% → 0.9%+107,545 shares
- Sherwin-Williams Company~$32.7MNew · 0.0% → 0.8%+118,212 shares
- St Jude Med Inc (Stj)PUT~$31.9MNew · 0.0% → 0.7%+400,000 underlying
- Pepsico Incorporated~$30.6MAdded · 0.5% → 1.3%+281,674 shares
Largest sells
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrustPUT~$1.22BCut · 37.0% → 13.8%−5,630,800 underlying
- SPDR Dow Jones Industrial Average ETF TrustPUT~$58.2MSold out · 1.2% → 0.0%−325,000 underlying
- Emc Corporation~$43.6MSold out · 0.9% → 0.0%−1,605,806 shares
- Starwood Hotels & Resorts~$40.3MSold out · 0.9% → 0.0%−544,333 shares
- Express Scripts Holding Co(Cl A)~$36.7MCut · 0.8% → 0.0%−521,000 shares
- Laboratory Corp. Of America Holdings~$32.1MCut · 0.7% → 0.0%−233,480 shares
- Post Holdings Inc~$28.0MCut · 0.7% → 0.0%−362,610 shares
- Fair Isaac (FICO)~$27.8MCut · 0.6% → 0.0%−222,846 shares
- Interactivecorp~$24.3MCut · 0.5% → 0.1%−388,943 shares
- Columbia Pipeline Group~$24.1MSold out · 0.5% → 0.0%−945,685 shares
Holdings
As of Sep 30, 2016. Changes are in shares against Jun 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrustCALLCOMMON STOCK · shares +121% | 16.1% | $686.8M | — | ||||||||
| SPDR S&P 500 ETF TrustPUTCOMMON STOCK · shares −67% | 13.8% | $587.1M | — | ||||||||
| SPDR S&P 500 ETF TrustCOMMON STOCK · shares New | 1.9% | $81.4M | — | ||||||||
| Ishares Msci Emerging Markets - ETFCOMMON STOCK · shares New | 1.6% | $69.9M | — | ||||||||
| Zimmer Biomet Holdings IncCOMMON STOCK · shares +1.0% · price +8.0% | 1.3% | $55.1M | +$4.0M | ||||||||
| Pepsico IncorporatedCOMMON STOCK · shares +127% · price +2.7% | 1.3% | $54.8M | +$628,080 | ||||||||
| Hologic Inc.COMMON STOCK · shares −8.4% · price +12.2% | 1.1% | $46.6M | +$5.1M | ||||||||
| Privatebancorp IncCOMMON STOCK · shares +57% · price +4.3% | 1.1% | $45.2M | +$1.2M | ||||||||
| Linkedin Corp - ACOMMON STOCK · shares +12% · price +1.0% | 0.99% | $42.5M | +$369,286 | ||||||||
| Biogen IncCOMMON STOCK · shares +593% · price +29.4% | 0.92% | $39.3M | +$1.3M | ||||||||
| Itc Holdings CorpCOMMON STOCK · shares +22% · price −0.7% | 0.92% | $39.1M | −$235,044 | ||||||||
| Merck & Co. IncorporatedCOMMON STOCK · shares +15,613% · price +8.2% | 0.90% | $38.2M | +$18,400 | ||||||||
| Cst Brands IncCOMMON STOCK · shares New | 0.84% | $36.1M | — | ||||||||
| Alliance Data Sys CorpCOMMON STOCK · shares +6,346% · price +9.5% | 0.81% | $34.8M | +$46,763 | ||||||||
| MetaCOMMON STOCK · shares +577% · price +12.2% | 0.81% | $34.6M | +$558,661 | ||||||||
| Sherwin-Williams CompanyCOMMON STOCK · shares New | 0.77% | $32.7M | — | ||||||||
| St Jude Med Inc (Stj)PUTCOMMON STOCK · shares New | 0.75% | $31.9M | — | ||||||||
| Syngenta-ADRCOMMON STOCK · shares +8.4% · price +14.1% | 0.72% | $30.8M | +$3.5M | ||||||||
| AlphabetCOMMON STOCK · shares +1,482% · price +14.3% | 0.72% | $30.6M | +$242,000 | ||||||||
| Vipshop Holdings Ltd - ADS - ADRCOMMON STOCK · shares +90% · price +31.3% | 0.68% | $29.2M | +$3.7M | ||||||||
| Johnson Controls International PlcCOMMON STOCK · shares New | 0.67% | $28.5M | — | ||||||||
| MastercardCOMMON STOCK · shares +4,113% · price +15.6% | 0.67% | $28.5M | +$91,348 | ||||||||
| Bard (C.R.) IncorporatedCOMMON STOCK · shares +11,427% · price −4.7% | 0.67% | $28.4M | −$12,289 | ||||||||
| Everbank Financial CorpCOMMON STOCK · shares New | 0.66% | $28.1M | — | ||||||||
| Media General IncorporatedCOMMON STOCK · shares +3.0% · price +7.2% | 0.65% | $27.7M | +$1.8M | ||||||||
| Total · 1,402 positions | 100% | $4.27B | +$81.5M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2016 to Q3 2016: 1,020 stocks held throughout, up $81.5M (+7.2%).
- Hologic Inc.+$5.1M+12%
- Zimmer Biomet Holdings Inc+$4.0M+8%
- Vipshop Holdings Ltd - ADS - ADR+$3.7M+31%
- Syngenta-ADR+$3.5M+14%
- Visa Inc.+$2.5M+12%
- Jazz Pharmaceuticals Plc−$360,012−14%
- Rubicon Project Inc/The−$544,393−39%
- Liberty Lilac Group−$625,639−14%
- Martin Marietta Materials Incorporated−$627,248−7%
- Liberty Lilac Group-C−$678,562−14%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $71.91B+33% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $53.87B−0% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $54.03B−7% | SEC ↗ |
| Q3 2025 | Dec 9, 2025 (amended) | $57.98B+26% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $45.92B+53% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $30.10B+15% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $26.28B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.48B+41% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $19.52B+24% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $15.72B+27% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $12.42B+25% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $9.97B+19% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $8.38B+30% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $6.46B+28% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $5.06B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $4.63B+22% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $3.81B−11% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $4.27B−29% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $5.98B−3% | SEC ↗ |
| Q3 2021 | Nov 17, 2021 (amended) | $6.16B+16% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $5.29B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $4.99B+41% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.54B+54% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $2.30B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.02B+81% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $1.12B−50% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $2.23B−23% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.91B−17% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.51B+45% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $2.42B−52% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $5.06B+27% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $3.98B+38% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.87B−7% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $3.09B−22% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $3.94B+0% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $3.92B+19% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $3.28B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $3.25B−16% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $3.88B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $4.27B−10% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $4.72B+21% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $3.91B | SEC ↗ |